Lumaad, Mark Eldrian T.
HRN: 23-53-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/31/2024
02/07/2024
IVT
60mg
Q8
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes